More languages
More actions
Eli Lilly and Company | |
|---|---|
 | |
| Industry | Pharmacy |
| Founder | Eli Lilly |
| Key people | David A. Ricks (Chairperson, President, & CEO) Anat Ashkenazi (Vice president & CFO)[1] |
| Ownership | Lilly Endowment, 11.6%[2] |
| Revenue | +US$22.319 billion (2019)[3] |
| Net income | +US$8.318 (2019)[3] |
| Total assets | -US$39.286 (2019)[3] |
| Website | |
| www.lilly.com | |
Eli Lilly and Company, often shortened to Eli Lilly, is a U.S-based pharmaceutical corporation.
Controversies
Prozac Jury corruption
On July 20, 2019; Eli Lilly was found to have bribed the Jury and victims of mass shootings 20 million dollars, in multiple lawsuits against Eli Lily for murder from Prozac, to hide evidence of Prozac increasing the rate of mass shootings.[4]
Off-label marketing of Zyprexa
In 2007, Eli Lilly and Company had paid $1.415 billion to resolve allegations regarding promotion of off-label usage of Zyprexa.[5] Eli Lilly also paid up to $800 million in a civil settlement with the federal government and the states.[5]
References
- ↑ Jaimy Lee (9 February 2021). Lilly promotes Anat Ashkenazi to CFO, says previous CFO had 'inappropriate' communication with employees Market Watch. Archived from the original on 9 February 2021.
- ↑ Document.
- ↑ 3.0 3.1 3.2 Eli Lilly and Company 2019 Annual Report (19 February 2020).
- ↑ Andrew Wolfson (2019-09-12T12:33Z−07:00). "Prozac maker paid millions to secure favorable verdict in mass shooting lawsuit, victims say"
- ↑ 5.0 5.1 "Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegationsof Off-label Promotion of Zyprexa" (2009-01-15). Office of Public Affairs.